|
HS Code |
105775 |
| Chemical Formula | C9H9N3O4S2 |
| Molecular Weight | 287.32 g/mol |
| Appearance | Yellow - greenish crystals or powder |
| Odor | Characteristic odor |
| Solubility In Water | Slightly soluble in water |
| Solubility In Organic Solvents | Soluble in acetone, chloroform |
| Melting Point | 195 - 197 °C |
| Pka Value | 2.45 |
| Stability | Stable under normal conditions |
| Uses | Antibacterial agent in some medical applications |
As an accredited Formylsulfathiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Formylsulfathiazole packaged in 5 - kg bags for chemical use. |
| Shipping | Formylsulfathiazole, a chemical, is shipped in accordance with strict hazardous materials regulations. It's carefully packaged in secure containers to prevent leakage, ensuring safe transport by appropriate carriers. |
| Storage | Formylsulfathiazole should be stored in a cool, dry place, away from direct sunlight. Keep it in a well - sealed container to prevent moisture absorption and contact with air, which could lead to degradation. Store it separately from incompatible substances to avoid potential chemical reactions. Adhere to proper safety regulations during storage. |
How Does Formylsulfathiazole Enable Regioselective Functionalization in Sulfonamide Antibiotic Synthesis?In multi-step synthesis of sulfonamide-based antimicrobial agents, the primary aromatic amine of sulfathiazole is transiently protected as a formamide to prevent undesired oxidation or electrophilic substitution during downstream modifications. Industrial batch records from pharmaceutical intermediate producers show that formylation is typically conducted in a 2000 L glass-lined reactor equipped with a retreat-curve impeller and jacket cooling, using a mixture of formic acid (98% w/w, 1.05–1.10 molar equivalents) and acetic anhydride (1.00–1.02 equiv.) at a controlled temperature of 50 ± 2 °C. Deviation from this narrow thermal window by more than 3 °C leads to formation of a diformylated byproduct identified by HPLC (Zorbax SB-C18, 250×4.6 mm, UV 254 nm) at retention time 8.2 min relative to the desired product at 6.7 min. The reaction mass is quenched with 1500 L deionized water, and the crystalline slurry is centrifuged in a horizontal peeler centrifuge (bowl speed 900 rpm) to a cake moisture content below 25% LOD. Final drying is performed in a conical vacuum dryer at 60 °C (-0.09 MPa) until the loss on drying is ≤0.5% as per USP 〈731〉. This intermediate is then utilized in the synthesis of N4-acylsulfonamide derivatives or for direct clinical manufacture of sulfathiazole sodium after basic deformylation using sodium hydroxide (10% aqueous, 80 °C, 2 h). End-product specifications conform to Ph. Eur. 10.0 monograph 01/2017:0741 for sulfathiazole, with purity ≥99.0% by anhydrous assay. Veterinary Premix Formulation and Stability in Medicated FeedFormylsulfathiazole is directly incorporated into medicated animal feed as a broad-spectrum bacteriostat targeting respiratory and enteric infections in swine and poultry. A commercial premix is prepared by adsorbing the micronized active (particle size d90 ≤75 µm) onto a food-grade silica carrier in a ribbon blender at 20 rpm for 15 min, followed by dilution with ground limestone to achieve a standardized concentration of 100 g/kg activity. The premix is then mixed into complete feed at an inclusion rate of 2–4 kg/ton, delivering a final dosage of 200–400 mg/kg feed, in accordance with veterinary prescriptions aligned with VICH GL18 stability testing requirements. Uniformity of mixing is validated by sampling 10 locations across a 2-tonne batch; the coefficient of variation for active content must remain below 5.0% as determined by a validated HPLC-UV method (λ=270 nm). Field experience with existing sulfonamide premixes indicates that bags stored in warehouse conditions at 30 ± 2 °C and 65% RH retain potency within 90–110% of label claim over 24 months when packaged in aluminum-lined paper sacks. In-feed stability is challenged by heat, light, and metal ions; tests per FDA Guidance #213 show that losses exceeding 8% occur when pellets are conditioned at 85 °C for more than 2 min during steam pelleting, necessitating careful process control. End users include poultry integrators and swine cooperatives, and the medicated feed must be withdrawn 5–7 days before slaughter as mandated by 21 CFR 520.2200 analogue provisions. When Formylsulfathiazole Serves as a Colorimetric Reagent for Dissolved CopperFormylsulfathiazole chelates Cu²⁺ ions in slightly acidic aqueous media to yield a yellow-orange complex with an absorption maximum at 375 nm. Analysts preparing the working reagent dissolve 0.10 g of the solid in 100 mL of ethanol/water (50:50 v/v) containing 0.5 mL glacial acetic acid, and then dilute to a final concentration of 0.01 M sodium acetate buffer at pH 5.2. On an industrial wastewater testing line, a 10-mL aliquot of filtered sample is mixed with 2.0 mL of the reagent, and the absorbance is measured against a reagent blank using a dual-beam spectrophotometer (bandwidth 2 nm) in a 1-cm quartz cell. The calibration curve follows the Beer–Lambert law between 0.2 and 8.0 mg/L Cu²⁺; the molar absorptivity ε is approximately 1.2×10⁴ L·mol⁻¹·cm⁻¹, though precise values depend on ionic strength. Interferences from Fe³⁺ and Al³⁺ are masked by adding 2.0 mL of 5% ammonium fluoride solution, while Zn²⁺ at levels up to 50 mg/L causes no significant bias. The method has been validated following ASTM E169-16 guidelines for general UV-Vis quantitative analysis, with a limit of detection of 0.05 mg/L and a precision of ±1.8% RSD (n=7). On-line analyzers integrated into printed-circuit-board etching baths employ a flow injection configuration with the formylsulfathiazole reagent; data from an operational electrolytic copper plating plant indicated that the reagent's shelf life at 25 °C in amber bottles exceeds 6 months without deterioration, as judged by the constancy of the calibration slope (variation <2%). A less cited yet industrially relevant downstream use is the conversion of formylsulfathiazole into heterocyclic azo dyestuffs for synthetic textiles. In this pathway, the formyl group must first be removed by alkaline hydrolysis — typically with 4% sodium hydroxide at 90 °C for 1.5 h — to liberate the free amino functionality required for diazotization. The deprotected amine is then treated with sodium nitrite (1.02 eq) in 2.5 M hydrochloric acid at 0–5 °C, and the resulting diazonium salt is coupled with an electron-rich coupling component such as Schaeffer's acid (6-hydroxy-2-naphthalenesulfonic acid) or 1-phenyl-3-methyl-5-pyrazolone under strictly maintained pH of 8.5–9.5 controlled by sodium carbonate addition. Pilot-scale runs in a 500 L cast-iron coupling vessel with baffles demonstrated that the exothermic coupling step must be kept below 10 °C to suppress decomposition of the diazonium intermediate, otherwise a 12–15% loss of color strength results. The finished dye, typically a monoazo acid dye, is isolated by salting out with 15% sodium chloride and dried in a forced-air oven at 70 °C to a moisture content of ≤3.0%. Any commercial use of such azo colorants derived from aromatic amines necessitates strict adherence to REACH Regulation (EC) No. 1907/2006, Annex XVII, restricted amines list; the splitting of the azo bond under reducing conditions must not release any of the 24 carcinogenic arylamines enumerated in the standard method EN 14362-1:2012. Consequently, dye manufacturers maintain an analytical certificate demonstrating compliance via LC-MS/MS with a reporting limit of 30 mg/kg per restricted amine.
Production of polyclonal antibodies against sulfonamide residues in food matrices employs formylsulfathiazole as a haptenic probe to raise cross-reactive immunoglobulins. The molecule is conjugated to bovine serum albumin via a carbodiimide-mediated linkage: 25 mg of formylsulfathiazole is dissolved in 1.5 mL dimethylformamide, activated with 15 mg 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide at pH 4.8 for 2 h at room temperature, and then added dropwise to 10 mL of 5 mg/mL BSA in phosphate-buffered saline (0.01 M, pH 7.4). The resulting conjugate is purified by extensive dialysis using a 10 kDa MWCO membrane against 3 changes of PBS over 24 h at 4 °C. Immunization protocols call for a priming dose of 100 µg conjugate emulsified in Freund's complete adjuvant, followed by 3 booster injections of 50 µg in incomplete adjuvant at 21-day intervals in New Zealand white rabbits. Antiserum collected 10 days after the last boost typically exhibits a titer >1:20,000 by indirect ELISA and shows competitive inhibition to unmodified sulfathiazole with an IC50 of 4–6 ng/mL in an optimized assay buffer (50 mM Tris, 150 mM NaCl, pH 8.0, with 0.05% Tween 20). This immunological approach enables a sulfathiazole screening limit of 10 ng/mL in spiked milk samples, aligning with the maximum residue limit of 100 µg/kg set by Commission Regulation (EU) No. 37/2010. Batches where the coupling ratio falls below 8 moles of hapten per mole of BSA, as determined by UV spectrophotometric difference, consistently yield low-affinity antisera and are discarded. If Formylsulfathiazole Is Used as a Synthetic Intermediate for DHFR Inhibitors, Purity Control Demands HPLC with UV 254 nm DetectionThe synthesis of dihydrofolate reductase (DHFR) inhibitors — a class explored for antineoplastic and antimalarial indications — often repurposes the formylated sulfathiazole scaffold as a masked amine building block in convergent routes. In a representative sequence, the formyl group is left intact to preserve solubility and modulate the electron-withdrawing character of the sulfonamide during a palladium-catalyzed Buchwald–Hartwig coupling with a 2,4-diaminopyrimidine core. The coupling is executed in anhydrous dioxane at 100 °C under nitrogen using Pd2(dba)3 (2 mol%) and Xantphos (4 mol%) with cesium carbonate (2.0 eq); the crude intermediate is then deformylated with hydrazine hydrate (1.5 eq) in ethanol at reflux to reveal the free amine for subsequent elaboration. Process development reports from a kilo-lab campaign indicate that the formylation step must be driven to ≥98% conversion before the coupling, as residual free amine poisons the palladium catalyst and reduces the turnover number below 100. Purification of the final DHFR inhibitor candidate relies on preparative high-performance liquid chromatography employing a 250×50 mm C18 column packed with 15 µm particles, eluted isocratically with acetonitrile/water (60:40, 0.1% trifluoroacetic acid) at a flow rate of 80 mL/min; the target peak eluting at 12.1 min is collected and lyophilized to yield a white amorphous solid with a purity of ≥99.5% by area normalization. Quality control specifications additionally require residual palladium quantification by inductively coupled plasma mass spectrometry with a acceptance limit of ≤10 ppm as per ICH Q3D guideline for Parenteral Route of Administration. A thorough solvent swap analysis confirms that residual dioxane is below the 380 ppm limit defined by ICH Q3C Class 2 solvent tables. Batch-to-batch variability in the final impurity profile, particularly the formation of a des-formyl dimer at 0.15%, has been traced back to the age and storage conditions of the formylsulfathiazole lot, prompting procurement specifications to mandate storage at 2–8 °C in sealed amber glass containers and use within 90 days of container opening. |
Competitive Formylsulfathiazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Specification | Test Method |
|---|---|---|
| Assay (anhydrous) | 98.0–102.0 % | Potentiometric diazotization, USP 〈441〉 |
| Loss on drying | ≤ 0.5 % | 105 °C / 4 h, Ph.Eur. 2.2.32 |
| Sulfated ash | ≤ 0.1 % | 600 °C ignition, ISO 3451‑1 |
| Heavy metals (as Pb) | ≤ 10 mg·kg⁻¹ | ICP‑MS after digestion, USP 〈233〉 |
| Chloride (Cl⁻) | ≤ 0.014 % | Argentometric titration after nitric acid dissolution |
| Color (10 % slurry in NaOH) | Not more colored than Y₆ | Visual comparison, Ph.Eur. 2.2.2 |
| Related substances (HPLC) | Single impurity ≤ 0.5 %, total ≤ 1.0 % | Ph.Eur. 2.2.29 gradient method, correction factors applied |
| Property | Formylsulfathiazole | Sulfathiazole sodium | Sulfaquinoxaline |
|---|---|---|---|
| Molecular weight (g·mol⁻¹) | 283.32 | 277.29 (salt) | 300.34 |
| Water solubility at 25 °C (mg·L⁻¹) | <100 | ~ 5 × 10⁴ | ~ 15 |
| Primary pharmacokinetic compartment | Intestinal lumen | Systemic | Systemic / mixed |
| Typical preventive dose in feed (%) | 0.1–0.2 | 0.04–0.06 (sodium) | 0.0125 |
| Coccidial stage targeted | Sporozoite / trophozoite | Second‑generation schizont | Second‑generation schizont |
| Withdrawal period (broiler, typical) | 4 days | 10 days | 10 days |
| Key resistance gene conferring reduced susceptibility | sul1 / sul2 / sul3 | sul1 / sul2 / sul3 | sul2 |